News, views and contacts from the global Pharmaceutical industry

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

May 2016

Top

AbbVie to take over Stemcentrx and its Rova-T therapy for SCLC for $5.8bn 03 May 2016 US-based biopharmaceutical company AbbVie will acquire biotechnology company Stemcentrx for nearly...

April 2016

Top

FDA approves use of orfadin oral suspension to treat Hereditary Tyrosinemia Type 1 29 April 2016 The Food and Drug Administration (FDA) has approved the use of Swedish Orphan Biovitrum's (Sobi's) orfadin oral suspension for the treatment of Hereditary Tyrosinemia Type 1...

M&As this week: Johnson & Johnson, DNA2.0 29 April 2016 Johnson & Johnson has announced its plans to acquire Neostrata, its affiliates and Tristrata...

Deals this week: Lexogen, PerkinElmer, Interprotein, Hainan Haiyao 29 April 2016 Lexogen and TATAA Biocentre have entered an agreement to distribute Lexogen's NGS products and expand their market size in Europe....

AstraZeneca's Lynparza available for BRCAm ovarian cancer patients in NHS England and Wales 29 April 2016 Biopharmaceutical company AstraZeneca has revealed that Lynparza (olaparib) is currently available for National Health Service (NHS) patients in England and Wales suffering from...

Report: South Korean pharmaceutical market to experience growth 29 April 2016 The South Korean pharmaceutical market is expected to rise by $1.8bn over the next four years, to reach $20.4bn in value by 2020, according to a recent report by GlobalData....

Zymeworks partners with GSK to develop bi-specific antibodies 28 April 2016 Privately-held biotherapeutics company Zymeworks has entered into a licensing agreement with GlaxoSmithKline Pharmaceuticals (GSK) to research, develop and market bi-specific...

Johnson & Johnson to acquire dermocosmetics company NeoStrata 28 April 2016 New Jersey-based Johnson & Johnson Consumer has entered into a definitive agreement to purchase US dermocosmetics company,...

Queen’s University and Domainex receive late-stage funding from Wellcome Trust 28 April 2016 Wellcome Trust Seeding Drug Discovery scheme has granted a late-stage funding to Queen’s University Belfast, Ireland, and UK-based Domainex to advance therapeutic candidate molecules into...

EC grants marketing authorisation for Gilead Sciences’ Descovy F/TAF 27 April 2016 The European Commission (EC) has granted marketing authorisation to biopharmaceutical company Gilead Sciences, for two doses of Descovy (emtricitabine and tenofovir alafenamide 200/10mg...

AM-Pharma receives fast track designation for recAP 27 April 2016 Netherlands-based biopharmaceutical company AM-Pharma has received fast track designation from the US Food and Drug Administration (FDA), for recombinant human Alkaline Phosphatase (recAP) to...

Helsinn partners with Purdue Pharma for Akynzeo distribution and licensing rights 27 April 2016 Swiss cancer care company Helsinn Group has signed an exclusive agreement with research-based pharmaceutical company Purdue Pharma Canada, for the distribution and licensing of...

NewLink Genetics receives contract option from BARDA to develop Ebola vaccine 26 April 2016 The Biomedical Advanced Research and Development Authority (BARDA) of the US Department of Health and Human Services (HHS) has awarded a $21.6m contract option to NewLink...

Chembio to conduct first oral fluid / saliva POC diagnostic test for malaria 26 April 2016 US-based Chembio Diagnostics has received a $678,000 grant from Seattle’s Bill and Melinda Gates Foundation, in a bid to accelerate the feasibility testing and development of the world’s first...

Sobi and Affibody sign licensing agreement to develop therapies for IL-1 related inflammatory diseases 26 April 2016 Healthcare company Swedish Orphan Biovitrum (Sobi) has exercised its option to sign a licensing agreement with biotech company...

Lannett and YiChang to develop generic insulin product for US market 25 April 2016 Generic pharmaceutical products developer and distributor Lannett Company has planned to develop a generic insulin pharmaceutical product for the US...

Ireland’s Allergan acquires US manufacturer Topokine Therapeutics 25 April 2016 Irish pharmaceutical giant Allergan has acquired Topokine Therapeutics, a US-based manufacturer of topical medicines for fat reduction, in a deal valued at...

Researchers say chemotherapy drug anthracyclines does not cause cognitive decline 25 April 2016 Researchers from the University of California, Los Angeles, (UCLA) have discovered that the chemotherapy drug, anthracyclines, does not result in cognitive impairments in women being treated...

Report: Keytruda and Opdivo to lead the immuno-oncology market 22 April 2016 A GlobalData report estimates that two drugs, Keytruda and Opdivo, are estimated to account for 50% of the global immuno-oncology market by...

AstraZeneca and partners to sequence genomes to discover new drugs 22 April 2016 AstraZeneca has teamed up with several partners to sequence genomes in an effort to discover and develop new drugs across all its therapeutic...

M&As this week: Chongqing Sansheng, Recipharm 22 April 2016 Building materials and chemicals company Chongqing Sansheng has revealed its plans to take over a pharmaceutical company also based in...


cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1243308781_ap1243308781_1857678299_874850511